Completed PHASE4 INTERVENTIONAL 3-arm NCT00586287

Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon

Prospective Randomized Trial of a Clinical Algorithm to Predict the Loading Dose of Phenprocoumon

Sponsor: Cantonal Hospital of St. Gallen

Conditions Atrial Fibrillation Hip Replacement Postoperative Knee Replacement Postoperative Pulmonary Embolism

Interventions Algorithm for phenprocoumon Phenprocoumon algorithm for phenprocoumon

Updated 6 times since 2017 Last updated: Mar 29, 2012 Started: Jan 31, 2007 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Atrial Fibrillation and Hip Replacement Postoperative and is currently completed. Cantonal Hospital of St. Gallen leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cantonal Hospital of St. Gallen

Data source: Cantonal Hospital of St. Gallen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sankt Gallen, Switzerland